Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1902
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population

Kumar Atul, Sinha Subijay

Year : 2007| Volume: 55| Issue : 6 | Page no: 451-455

   This article has been cited by
 
1 Prospective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edema
Romualdo Malagola,Giovanni Spinucci,Carmela Cofone,Luigi Pattavina
International Ophthalmology. 2013; 33(3): 261
[Pubmed]  [Google Scholar] [DOI]
2 Phacoemulcification with Intravitreal Bevacizumab Injection in Patients with Cataract and Coexisting Diabetic Retinopathy: Prospective Randomized Study
Ali Salehi,Afsaneh Naderi Beni,Hassan Razmjoo,Zahra Naderi Beni
Journal of Ocular Pharmacology and Therapeutics. 2012; 28(3): 212
[Pubmed]  [Google Scholar] [DOI]
3 Meta-analysis and review on the effect of bevacizumab in diabetic macular edema
Sunali Goyal, Michael LaValley, Manju L. Subramanian
Graefe s Archive for Clinical and Experimental Ophthalmology. 2011; 249(1): 15
[HTML Full text]  [Google Scholar] [DOI]
4 A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS :
Margriet I Van der Reis, Ellen C La Heij, Yvonne De Jong-Hesse, Peter J Ringens, Fred Hendrikse, Jan S A G Schouten
Retina. 2011; 31(8): 1449
[HTML Full text]  [Google Scholar] [DOI]
5 Comparison of Intravitreal Triamcinolone Versus Bevacizumab in Bilateral Diabetic Macular Edema by Optical Coherence Tomography (OCT) Patterns
Sang Hyun Kim, Jung Min Park
Journal of the Korean Ophthalmological Society. 2010; 51(2): 210
[HTML Full text]  [Google Scholar] [DOI]
6 A review of clinical trials of anti-VEGF agents for diabetic retinopathy
Benjamin P. Nicholson, Andrew P. Schachat
Graefe s Archive for Clinical and Experimental Ophthalmology. 2010; 248(7): 915
[HTML Full text]  [Google Scholar] [DOI]
7 Management of cataract with macular oedema due to diabetes mellitus type-II and hypertension with grid laser prior to surgery and intra-vitreal bevacizumab (Avastin) peroperatively
Wahab, S., Ahmed, J.
Journal of the Pakistan Medical Association. 2010; 76(10): 836-839
[Pubmed]  [Google Scholar]
8 Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema | [Die rolle der Anti-VEGF-therapie in der behandlung desdiabetischen makuladems]
Kakkassery, V., Winterhalter, S., Joussen, A.M.
Klinische Monatsblatter fur Augenheilkunde. 2010; 227(9): 701-711
[Pubmed]  [Google Scholar]
9 Intravitreal Bevacizumab with or without triamcinolone for refractory diabetic macular oedema
Synek, S., Vojnikovič, B.
Collegium Antropologicum. 2010; 34(sup 2): 99-103
[Pubmed]  [Google Scholar]
10 Multifocal electroretinography assisted comparison of macular photocoagulation versus macular photocoagulation and intravitreal bevacizumab injection in diabetic macular edema
Abdollahi, A., Movassat, M., Ahmadabadi, M.N., Abdollahi, M., Bashiri, A.
Iranian Journal of Ophthalmology. 2010; 22(3): 23-28
[Pubmed]  [Google Scholar]
11 Tunnelled versus straight intravitreal injection: Intraocular pressure changes, vitreous reflux, and patient discomfort
Knecht, P.B., Michels, S., Sturm, V., Bosch, M.M., Menke, M.N.
Retina. 2009; 29(8): 1175-1181
[Pubmed]  [Google Scholar]
12 Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema
Ophthalmology. 2009; 116(8): 1488
[HTML Full text]  [Google Scholar] [DOI]
13 Primary treatment of diabetic macular edema
Ranchod, T.M., Fine, S.L.
Clinical Interventions in Aging. 2009; 4(1): 101-107
[Pubmed]  [Google Scholar]
14 TUNNELLED VERSUS STRAIGHT INTRAVITREAL INJECTION
PASCAL BRUNO KNECHT,STEPHAN MICHELS,VEIT STURM,MARTINA MONIKA BOSCH,MARCEL NICO MENKE
Retina. 2009; 29(8): 1175
[Pubmed]  [Google Scholar] [DOI]
15 Off with the label and on the Avastin bandwagon: Why now and how far
Santhan Gopal, K.S.
Indian Journal of Ophthalmology. 2009; 57(4): 253-256
[Pubmed]  [Google Scholar]
16 Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema. The Pan-American Collaborative Retina Study Group at 24 Months
Arevalo, J.F., Sanchez, J.G., Wu, L., Maia, M., Alezzandrini, A.A., Brito, M., Bonafonte, S., (...), Udaondo-Mirete, P.
Ophthalmology. 2009; 116(8): 1488-1497,e1
[Pubmed]  [Google Scholar]
17 Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
Arevalo, F., Sanchez, J.G., Fromow-Guerra, J., Wu, L., Berrocal, M.H., Farah, M.E., Cardillo, J., Rodríguez, F.J.
Graefećs Archive for Clinical and Experimental Ophthalmology. 2009; 247(6): 735-743
[Pubmed]  [Google Scholar]
18 Treatment progress of diabetic macular edema
Chen, T.-Y., Chen, X.-Y.
International Journal of Ophthalmology. 2009; 9(3): 531-534
[Pubmed]  [Google Scholar]
19 Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy. Prospective randomized study
Cheema, R.A., Al-Mubarak, M.M., Amin, Y.M., Cheema, M.A.
Journal of Cataract and Refractive Surgery. 2009; 35(1): 18-25
[Pubmed]  [Google Scholar]
20 Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy
Rizwan A. Cheema, Mahdi M. Al-Mubarak, Yasir M. Amin, Maheera A. Cheema
Journal of Cataract & Refractive Surgery. 2009; 35(1): 18
[HTML Full text]  [Google Scholar] [DOI]
21 Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
Simó, R., Hernández, C.
Diabetologia. 2008; 51(9): 1574-1580
[Pubmed]  [Google Scholar]
22 Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
R. Simó,C. Hernández
Diabetologia. 2008; 51(9): 1574
[Pubmed]  [Google Scholar] [DOI]

 

Read this article